SCHEMBL3433286

SCHEMBL3433286

CCOC(=O)c1ccc2cccc(Cl)c2n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
MAPT P10636 2/20 0.50
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPK1 P28482 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
GABRA2 P47869 3/20 0.43
GABRB2 P47870 3/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17652250 0.84 CYP1A2 (0.63) CYP1A2MAPTKMT2AGAAKDM4E
SCHEMBL28430253 0.84 CYP1A2 (0.54) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL28426558 0.82 CYP1A2 (0.61) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL27285116 0.81 CYP1A2 (0.59) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL2783408 0.81 CYP1A2 (0.59) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL6197085 0.81 CYP1A2 (0.51) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL1478915 0.77 CYP1A2 (1.00) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL1095857 0.76 CYP1A2 (0.77) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL31337797 0.76 CYP1A2 (0.77) CYP1A2MAPTNPC1RAB9AKMT2A
SCHEMBL1725005 0.76 KDM4E (0.66) KMT2AMEN1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2265614-A1 IMIDAZO [1,2-B]PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE Novartis AG (CH) 2010-12-29 EP disclosed
WO-2009106577-A1 IMIDAZO [1,2-B] PYRIDAZINE DERIVATIVES FOR THE TREATMENT OF C-MET TYROSINE KINASE MEDIATED DISEASE NOVARTIS AG (CH) 2009-09-03 WO disclosed